“When a measure becomes a target, it ceases to be a good measure”
Today’s complex clinical trials yield data sets that are almost unimaginably large and complex. As a result, the process of transforming trial data into usable knowledge simply cannot be accomplished using traditional presentation methods such as conventional charts and graphs.
Owlstone Nanotech, the developers of a promising new lung cancer detection instrument have announced they are now moving their device into clinical trials. The trials are said to begin later this year in a rapid access lung cancer clinic at Glenfield Hospital in Leicester, England.
Statsols, on Jan 26, 2015
The experimental ZMapp treatment created by Mapp Biopharmaceutical will soon begin human clinical trials in the United States and Liberia, following efforts to boost production capacity.
Statistical Solutions is 30 years old, and we would like to thank all of our wonderful, loyal customers for all your support over the last 3 decades!!! Thank you and best wishes from all the team at Statistical Solutions. Read more about our history here.
Statsols, on Jul 29, 2014
Enjoy the celebrations and be happy and safe.
Homeward bound from DIA 2014 50th Annual Meeting in San Diego. Big thank you to all the organisers for doing such a great job. This year excelled itself with so many excellent talks, workshops, tutorials and symposiums. See you all again next year.
A good statistical study is one that is well designed and leads to valid conclusions. This however, is not always the case, even in published studies. In Cohen’s (1962) seminal power analysis of the journal of Abnormal and Social Psychology he concluded that over half of the published studies were insufficiently powered to result in statistical significance for the main hypothesis.
Statsols, on Jun 12, 2014
Great Blog post from RxObserver